BBWI
Bath & Body Works, Inc.
NYSEUSDEQUITY
Consumer Cyclical
DELAYED
Last price
19.57
▲ 0.13 (0.67%)
MARKET · —
Price
Open
19.64
Prev close
19.44
Day high
19.66
Day low
19.23
Volume
5.55M
Market cap
$3.92B
P/E (TTM)
5.53
52W range
14.28 – 32.32
Trailing performance
Returnvs SPY
1W
+0.21%
+1.6%
1M
+0.57%
-3.2%
3M
+12.30%
+9.2%
6M
-20.22%
-31.3%
YTD
-3.14%
-15.4%
1Y
-34.33%
-54.3%
3Y
-48.11%
-122.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$3.92B
Enterprise value$7.82B
Revenue (TTM)$7.25B
Gross profit$3.13B
EBITDA$1.35B
Net income$727.00M
EPS (TTM)$3.52
Free cash flow$729.00M
Total cash$820.00M
Total debt$4.71B
Book value / share$-5.64
Shares outstanding201.56M
Float200.66M
Short % of float7.79%
Dividend yield4.11%
Beta (5Y)1.38
Valuation & profitability ratios
Trailing P/E5.53
Forward P/E6.78
PEG ratio0.76
Price / sales—
Price / book—
EV / revenue1.08
EV / EBITDA5.79
Gross margin43.23%
Operating margin10.96%
Profit margin10.04%
Return on equity—
Return on assets13.94%
Debt / equity—
Current ratio1.38
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Total revenue | $7.29B | $7.31B | $7.43B | $7.56B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $649.00M | $798.00M | $878.00M | $800.00M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | $649.00M | $798.00M | $878.00M | $800.00M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Apr 2026 | 0.29 | 0.32 | +10.0% |
| Jan 2026 | 1.77 | 2.05 | +15.8% |
| Oct 2025 | 0.40 | 0.35 | -11.9% |
| Jul 2025 | 0.38 | 0.37 | -1.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.24 | 17 | $1.50B | -3.4% |
| Next quarter | 0.26 | 17 | $1.55B | -2.9% |
| Current year | 2.65 | 18 | $7.09B | -2.7% |
| Next year | 2.87 | 18 | $7.23B | +2.0% |
Analyst targets & ownership
Mean target$25.33
High target$54.00
Low target$19.00
Implied upside29.45%
Analyst count15
ConsensusHOLD
Strong buy / Buy0 / 5
Hold12
Sell / Strong sell1 / 0
Held by insiders0.53%
Held by institutions106.09%
Institutions holding636
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.07M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 10, 26 | ABER ANN Officer |
STOCK | 12.94K | $0 | Direct |
| Jun 12, 26 | JAVITCH TOM Chief Financial Officer |
STOCK | 10.31K | $0 | Direct |
| Jun 11, 26 | SYMANCYK JAMES KEVIN Director |
STOCK | 7.97K | $0 | Direct |
| Jun 11, 26 | STEINOUR STEPHEN D Director |
STOCK | 7.97K | $0 | Direct |
| Jun 11, 26 | HONDAL FRANCIS A Director |
STOCK | 7.97K | $0 | Direct |
| Jun 11, 26 | LEE DANIELLE M Director |
STOCK | 7.97K | $0 | Direct |
| Jun 11, 26 | VOSKUIL STEVEN E Director |
STOCK | 7.97K | $0 | Direct |
| Jun 11, 26 | BOGLIOLO ALESSANDRO Director |
STOCK | 7.97K | $0 | Direct |
| Jun 11, 26 | NASH SARAH E Director |
STOCK | 13.28K | $0 | Direct |
| Jun 11, 26 | RAJLIN JUAN Director |
STOCK | 7.97K | $0 | Direct |
| Jun 11, 26 | BRADY LUCY Director |
STOCK | 7.97K | $0 | Direct |
| May 19, 26 | MAZUREK THOMAS E Officer |
STOCK | 6.62K | $0 | Direct |
| Mar 12, 26 | BORATTO EVA C Chief Financial Officer |
STOCK | 115.81K | $0 | Direct |
| Mar 12, 26 | MAZUREK THOMAS E Officer |
STOCK | 40.92K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BORATTO EVA C |
Chief Financial Officer | 223.46K | Stock Award(Grant) |
BOSWELL GINA R |
Chief Executive Officer | 332.71K | Stock Award(Grant) |
HEAF DANIEL |
Chief Executive Officer | 295.58K | Stock Award(Grant) |
JAVITCH TOM |
Chief Financial Officer | 59.00K | Stock Award(Grant) |
MAZUREK THOMAS E |
Officer | 115.17K | Stock Award(Grant) |
NASH SARAH E |
Director | 298.89K | Stock Award(Grant) |
STEINOUR STEPHEN D |
Director | 88.87K | Stock Award(Grant) |
SYMANCYK JAMES KEVIN |
Director | 48.35K | Stock Award(Grant) |
VOSKUIL STEVEN E |
Director | 41.90K | Stock Award(Grant) |
WU MICHAEL C |
Officer | 88.92K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
19.20
+1.94% from price
SMA 20
19.80
-1.78% from price
SMA 50
20.38
-4.57% from price
SMA 100
19.51
+0.33% from price
SMA 200
20.23
-3.85% from price
EMA 12
19.55
+0.12% from price
EMA 26
19.79
-1.13% from price
EMA 50
19.90
-1.64% from price
RSI (14)
47.3
Neutral
MACD (12,26,9)
-0.25
Hist 0.01
ATR (14)
0.87
4.49% of price
Realised vol 30D
44.0%
Annualised
Bollinger upper
21.36
20, 2σ
Bollinger lower
18.25
20, 2σ
50 / 200 cross
Golden
20.38 vs 20.23
Trend bias
Below 200
-3.85%
Risk profile
Beta vs SPY
1.42
More volatile than market
Correlation to SPY
0.31
Loosely linked
Realised vol 30D
44.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-53.4%
Peak to trough
Max drawdown 5Y
-81.1%
Peak to trough
ATR 14
0.87
4.49% of price
Beta (reported)
1.38
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.45
Call-heavy session
Put / call open interest
0.29
Positioning, not flow
Max pain
19.00
-2.3% from spot
ATM implied vol
111.6%
Nearest strike to spot
Skew (10% OTM)
-3.5%
Calls bid over puts
Call volume
1.06K
Contracts, this expiry
Put volume
474
Contracts, this expiry
Heaviest call OI
21.00
1.79K contracts
Heaviest put OI
16.00
368 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Unlocking Q2 Potential of Bath & Body Works (BBWI): Exploring Wall Street Estimates for Key Metrics
Zacks · 1d ago
Ulta Beauty (ULTA) Earnings Expected to Grow: Should You Buy?
Zacks · 2d ago
Stocks making big moves yesterday: ADP, Northrop Grumman, Bath and Body Works, DoorDash, and Adobe
StockStory · 3d ago
Bath & Body Works' Q2 EPS Expected to Be in Line With Expectations, UBS Says
MT Newswires · 3d ago
Bath & Body Works (BBWI) Stock Looks Below Fair Value As Caution Lingers
Simply Wall St. · 3d ago
Is Bath & Body Works (BBWI) Using Dividends And Disney Deals To Redefine Its Brand Moat?
Simply Wall St. · 4d ago
Bath & Body Works (BBWI) Could Be 45% Undervalued On Its Growth Narrative
Simply Wall St. · 4d ago
Why Bath and Body Works (BBWI) Stock Is Trading Up Today
StockStory · 4d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.